GlassScriptPhysician profile
Shannon M Lensing
NPI 1487981320
$11,424.88
in general payments reported to CMS, 2019-2025
20 companies · $1,729 in 2025
The $1,729 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $109 · 2021: $395 · 2022: $3,846 · 2023: $2,891 · 2024: $1,939 · 2025: $1,729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,788 · Travel and Lodging: $2,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,788.08 |
| Travel and Lodging | $2,769.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,935.94 | 2019-2025 | Prostep, Ortholoc 2 Lapifuse, Augment Injectable |
| Organogenesis INC. | $2,425.53 | 2019-2025 | Novachor, Puraply Wound Matrix, Apligraf |
| Arthrex, INC. | $1,455.68 | 2022 | |
| Paragon 28, INC. | $1,245.75 | 2020-2022 | |
| Conetic Solutions, INC. | $619.13 | 2021-2023 | |
| Musculoskeletal Transplant Foundation INC. | $529.30 | 2019-2023 | |
| Smith+Nephew, INC. | $385.72 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Grafix Pl, Collagenase Santyl |
| Orthofix Medical, INC. | $148.34 | 2019-2025 | Physio-Stim, Accelstim |
| Paratek Pharmaceuticals, INC. | $115.22 | 2022-2025 | Nuzyra |
| Penumbra, INC. | $106.05 | 2019 | |
| Depuy Synthes Sales INC. | $100.46 | 2021-2024 | Na, Motoband, Hammerlock |
| Kerecis Limited | $90.89 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Horizon Therapeutics Plc | $48.72 | 2020-2021 | |
| Solventum Corporation | $46.81 | 2024 | Activ.A.C., Promogran Prisma |
| Convatec INC. | $40.59 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $38.43 | 2023 | Stimulan |
| Nevro Corp. | $36.27 | 2023 | Senza |
| Hydrofera LLC | $27.17 | 2023 | Hydrofera Blue |
| Medtronic, INC. | $15.11 | 2023 | Intellis Adaptivestim |
| Integra Lifesciences Corporation | $13.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Lensing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.